STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 43 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $13,866,000 | -49.4% | 2,858,928 | -37.4% | 8.64% | -11.4% |
Q2 2018 | $27,394,000 | -2.7% | 4,565,633 | +43.5% | 9.74% | +7.4% |
Q1 2018 | $28,162,000 | +176.3% | 3,182,149 | +126.3% | 9.07% | +166.9% |
Q4 2017 | $10,194,000 | +256.2% | 1,406,095 | +239.0% | 3.40% | +208.2% |
Q3 2017 | $2,862,000 | – | 414,773 | – | 1.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACUTA CAPITAL PARTNERS, LLC | 978,907 | $6,865,000 | 3.28% |
RA Capital Management | 2,690,702 | $20,449,000 | 2.02% |
NEA Management Company, LLC | 2,141,308 | $16,274,000 | 1.04% |
Broadfin Capital, LLC | 1,656,705 | $10,911,000 | 0.67% |
Tredje AP-fonden | 909,581 | $6,913,000 | 0.44% |
Granite Point Capital Management, L.P. | 388,945 | $2,679,000 | 0.40% |
Ghost Tree Capital, LLC | 72,726 | $553,000 | 0.23% |
SPHERA FUNDS MANAGEMENT LTD. | 181,818 | $1,382,000 | 0.20% |
Tower Research Capital LLC (TRC) | 1,094 | $8,000 | 0.00% |
ACADIAN ASSET MANAGEMENT LLC | 1,373 | $10,000 | 0.00% |